Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma

MI Canut1 Glaucoma SectionCorrespondence[email protected]

A Alvarez2 Barraquer Ophthalmology Centre

J Nadal3 Retina and Vitreous Unit, Macula Section, Institut Universitari Barraquer, Universidad Autonoma de Barcelona, Barcelona, Spain

R Abreu4 Retina and Vitreous Unit, University Hospital of La Candelaria, Tenerife

JA Abreu5 Glaucoma Section, University Hospital of the Canary Islands, Tenerife, Spain

JS Pulido6 Retina and Vitreous Unit, Ophthalmology Department, Mayo Clinic, Rochester, MN, USA

Pages 715-719 | Published online: 24 May 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

BrownGCMagargalLESchachatNeovascular glaucoma. Etiologic considerationsOphthalmology19849143153206201791
PubMed Web of Science ®Google Scholar
AllinghamRADamjiKFFreedmanSGlaucomas associated with disorders of the retina, vitreous and choroids Shields′Textbook of Glaucoma5th edPhiladelphia, PALippincott, Williams, and Wilkins2005
Google Scholar
IlievMEDomigDWolf-SchnurrburschUWolfSSarraGMIntravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucomaAm J Ophthalmol200614261054105617157590
PubMed Web of Science ®Google Scholar
MasonJO3rdAlbertMAJrMaysAVailRRegression of neovascular iris vessels by intravitreal injection of bevacizumabRetina200626783984116963866
PubMed Web of Science ®Google Scholar
Silva PaulaJJorgeRAlves CostaRRodrigues MdeLScottIUShort-term results of intravitreal bevacizumab (Avastin®) on anterior segment neovascularization in neovascular glaucomaActa Ophthalmol Scand200684455655716879583
PubMedGoogle Scholar
GhanemAAEl-KannishyAMEl-WehidyASIntravitreal bevacizumab (Avastin) as an adjuvant treatment in cases of neovascular glaucomaMiddle East Afr J Ophthalmol2009162757920142965
PubMedGoogle Scholar
DouatJAuriolSMahieu-DurringerLIntravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 casesJ Fr Ophtalmol2009329652663 French.19892433
PubMed Web of Science ®Google Scholar
CiftciSSakalarYBUnluKIntravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucomaEur J Ophthalmol20091961028103319882572
PubMed Web of Science ®Google Scholar
YazdaniSHendiKPakravanMIntravitreal bevacizumab for neovascular glaucoma: A randomized controlled trialJ Glaucoma200918863263719826393
PubMed Web of Science ®Google Scholar
HasanreisogluMWeinbergerDMimouniKIntravitreal bevacizumab as an adjunct treatment for neovascular glaucomaEur J Ophthalmol200919460761219551676
PubMed Web of Science ®Google Scholar
DuchSBuchacraOMillaEIntracameral bevacizumab (Avastin) for neovascular glaucoma: A pilot study in 6 patientsJ Glaucoma200918214014319225351
PubMed Web of Science ®Google Scholar
WakabayashiTOshimaYSakaguchiHIntravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive casesOphthalmology200811591571158018440643
PubMed Web of Science ®Google Scholar
DavidorfFHMouserJGDerickRJRapid improvement of rubeosis iridis from a single bevacizumab (Avastin®) injectionRetina200626335435616508439
PubMed Web of Science ®Google Scholar
GrisantiSBiesterSPetersSTatarOZiemssenFBartz-SchmidtKUTuebingen Bevacizumab Study GroupIntracameral bevacizumab for iris rubeosisAm J Ophthalmol2006142115816016815268
PubMed Web of Science ®Google Scholar
KahookMYSchumanJSNoeckerRJIntravitreal bevacizumab in a patient with neovascular glaucomaOphthalmic Surg Lasers Imaging200637214414616583637
PubMedGoogle Scholar
SugimotoYMochizukiHOkumichiHEffect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patientsGraefes Arch Clin Exp Ophthalmol2010248111601160920524132
PubMed Web of Science ®Google Scholar
SemounOBlumen-OhanaEde PreobrajenskyNAcute angle-closure glaucoma complicating an intravitreal injection of bevacizumabJ Fr Ophtalmol200932158.e14 French.19515315
PubMed Web of Science ®Google Scholar
MoraczewskiALLeeRKPalmbergPFOutcomes of treatment of neovascular glaucoma with intravitreal bevacizumabBr J Ophthalmol200993558959319074917
PubMed Web of Science ®Google Scholar
AlkawasAAShahienEAHusseinAMManagement of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin CJ Glaucoma201019962262620179624
PubMed Web of Science ®Google Scholar
SaitoYHigashideTTakedaHClinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumabAm J Ophthalmol20101496964972.e120381786
PubMed Web of Science ®Google Scholar
VasudevDBlairMPGalassoJIntravitreal bevacizumab for neovascular glaucomaJ Ocul Pharmacol Ther200925545345819857107
PubMed Web of Science ®Google Scholar
LupinacciAPCalzadaJIRafieeteryMClinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumabAdv Ther200926220821619234680
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date